CS logo
small CS logo
Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre

Halifax, Nova Scotia, Canada
Hospital in Halifax, Nova Scotia
5788 University Ave, Halifax, NS B3H 1V8

About Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
NCIC Clinical Trials Group
4
Pfizer
2
Alliance for Clinical Trials in Oncology
1
European Organisation for Research and Treatment of Cancer - EORTC
1
Odonate Therapeutics, Inc.
1
Radiation Therapy Oncology Group
1
Total Rows: 6

Clinical Trials at Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre


During the past decade, Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100Started TrialsCompleted Trails201700.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery
1996-07-04
2009-12-21
Completed
116
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia
2002-08-01
2009-12-01
Completed
27
Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
2002-12-01
2009-02-01
Completed
472
Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
2003-10-01
2012-11-01
Completed
732
Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer
2003-08-28
2009-02-10
Completed
572
SB-715992 in Treating Patients With Metastatic or Recurrent Malignant Melanoma
2004-11-01
2008-09-01
Completed
17
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
2007-07-01
2014-09-01
Completed
223

Rows per page:

1–10 of 10

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre" #1 sponsor was "NCIC Clinical Trials Group" with 4 trials, followed by "Pfizer" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored and "Odonate Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator and "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNCIC Clinical Trials Group: 4NCIC Clinical Trials Group: 4Pfizer: 2Pfizer: 2Alliance for ClinicalTrials in Oncology: 1Alliance for ClinicalTrials in Oncology: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1Odonate Therapeutics, Inc.: 1Odonate Therapeutics, Inc.: 1Radiation TherapyOncology Group: 1Radiation TherapyOncology Group: 1

Created with Highcharts 11.1.0Top CollaboratorsNational Cancer Institute (NCI): 4National Cancer Institute (NCI): 4NCIC Clinical Trials Group: 2NCIC Clinical Trials Group: 2Astellas Pharma Inc: 1Astellas Pharma Inc: 1Australasian Gastro-Intestinal Trials Group:1Australasian Gastro-Intestinal Trials Group:1Australasian Leukaemiaand Lymphoma Group:1Australasian Leukaemiaand Lymphoma Group:1Eastern CooperativeOncology Group: 1Eastern CooperativeOncology Group: 1Lymphoma Trials Office: 1Lymphoma Trials Office: 1Medivation LLC, awholly ownedsubsidiary of Pfizer Inc.:1Medivation LLC, awholly ownedsubsidiary of Pfizer Inc.:1Nordic Lymphoma Group: 1Nordic Lymphoma Group: 1Stichting Hemato-Oncologie voorVolwassenenNederland: 1Stichting Hemato-Oncologie voorVolwassenenNederland: 1

Clinical Trials Conditions at Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre


According to Clinical.Site data, the most researched conditions in "Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre" are "Lymphoma" (3 trials), "Advanced Breast Cancer" (1 trials), "Advanced Gastric Cancer" (1 trials), "Advanced/Metastatic Non-Small Cell Lung Cancer" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre" in a lesser frequency.

Clinical Trials Intervention Types at Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre


Most popular intervention types in "Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre" are "Drug" (6 trials), "Biological" (3 trials), "Dietary Supplement" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "CHOP regimen" (1 trials), "Capecitabine" (1 trials), "Enzalutamide" (1 trials), "Juven" (1 trials) and "Non-Juven Supplement" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre


The vast majority of trials in "Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre" are 8 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre


Currently, there are NaN active trials in "Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6Not Applicable: 2Not Applicable: 2Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Terminated: 1Terminated: 1